---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-26-002359"
form_type: "8-K"
ticker: "VSEE"
cik: "0001864531"
company_name: "VSEE HEALTH, INC."
filed_at: "2026-06-05T20:15:29+00:00"
generated_at: "2026-06-05T20:26:22.241507+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# VSee Health sells VSee Lab to co-CEO Chen; Chen resigns, Aisiku becomes sole CEO and Chairman

## Summary
- VSee Health sold all equity of VSee Lab to Milton Chen in exchange for Chen's 2,870,069 shares of VSEE common stock, effectively retiring those shares.
- Chen resigned as co-CEO and Chairman effective May 31, 2026; Dr. Imoigele Aisiku appointed as sole CEO and Chairman.
- Pro forma net loss improves: Q1 2026 from $2.6M to $1.26M; FY2025 from $14.7M to $10.0M, driven by elimination of VSee Lab's operations.
- VSee Lab contributed $1.28M in Q1 2026 revenue and $7.3M in FY2025 revenue; all revenues and costs removed from ongoing results.
- Transaction is a related-party exchange; company retains pre-closing liabilities of VSee Lab; Chen assumes post-closing liabilities.

## SEC filing metadata
- accession: 0001185185-26-002359
- form_type: 8-K
- ticker: VSEE
- cik: 0001864531
- company_name: VSEE HEALTH, INC.
- filed_at: 2026-06-05T20:15:29+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/0001185185-26-002359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/vsee8k060526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-26-002359
- JSON: https://secwatch.observer/filing/0001185185-26-002359.json
- Plain text: https://secwatch.observer/filing/0001185185-26-002359.txt

## Key facts
- Executive change
  Milton Chen resigned as co-Chief Executive Officer and Chairman at VSEE HEALTH, INC..
  - Action: resigned
  - Role: co-Chief Executive Officer and Chairman
  source text: Mr. Chen’s resignation was not because of any disagreement between Mr. Chen and the Company on any matter relating to the Company’s operations, policies or practices.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/0001185185-26-002359-index.htm
- Executive change
  Imoigele Aisiku was appointed as sole Chief Executive Officer and Chairman of the Board at VSEE HEALTH, INC..
  - Action: appointed
  - Role: sole Chief Executive Officer and Chairman of the Board
  source text: Dr. Imoigele Aisiku, the Company’s co-Chief Executive Officer, was appointed as the sole Chief Executive Officer and the chairman of the board of directors of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/0001185185-26-002359-index.htm
- M&A Transactions
  VSEE HEALTH, INC. completed a disposition involving Milton Chen for 2,870,069 shares of Common Stock (closed 2026-05-31).
  - Action: disposition
  - Counterparty: Milton Chen
  - Consideration: 2,870,069 shares of Common Stock
  - Closing: 2026-05-31
  source text: Agreement, Mr. Chen has agreed to transfer to the Company all of the common stock, par value $0.0001 per share (the “Common Stock”), of the Company that he currently owns, or 2,870,069 shares of Common Stock. In connection with the execution of the Purchase Agreement, Mr. Chen resigned as co-Chief Executive Officer and chairman of the board of directors of the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/0001185185-26-002359-index.htm
- Material Agreements
  VSEE HEALTH, INC. entered into Stock Purchase Agreement with Milton Chen valued at all of the equity securities of VSee Lab (effective 2026-05-31).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Milton Chen
  - Value: all of the equity securities of VSee Lab
  - Effective: 2026-05-31
  source text: On May 31, 2026, VSee Health, Inc., a Delaware corporation (the "Company") entered into a Stock Purchase Agreement (the "Purchase Agreement") with Milton Chen, the Company's co-Chief Executive Officer and Chairman of the Board and the Chief Executive Officer of VSee Lab, Inc., a Delaware Corporation and wholly-owned subsidiary of the Company ("VSee Lab").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/0001185185-26-002359-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.